Additionally, in both gemcitabine-treated normal pancreatic cancer cells and drug-resistant cells at low concentrations, STK33 protein expression was upregulated, with its higher expression level was found in drug-resistant cells (Fig. 3I, J). The gene discussed is STK33; the disease is pancreatic neoplasm.